GLP-1 Agonists and Weight Loss—Where Are We Now?

This presentation will review the research evidence regarding the role of GLP-1 agonists, nutrition, and lifestyle changes in the management of overweight and obesity.

Participants are expected to watch the video, reflect on its content, and complete the CEU self-assessment and CEU evaluation. Only upon completing this process will a participant's continuing education certificate be generated. The estimated time a learner will need to complete this self-study activity is 45 minutes. 

This activity is approved for continuing education for physicians, nurses, and dietitians. 

The George Washington University School of Medicine and Health Sciences designates this enduring activity for a maximum of 0.75 AMA PRA Category 1 Credit(s)™. 

Objectives: 

• Describes the risks, limitations, and benefits of GLP-1 agonists in the treatment of obesity.
• Describe the role of nutrition and lifestyle changes in the treatment of obesity. 

Requirements for successful completion: Participants will be awarded contact hours commensurate with participation after completion of the post-test with a score of 70% or higher.